+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Nanobiotix  - logo

Nanobiotix is a nanomedicine company dedicated to the development of new treatments for cancer based on the combined application of nanotechnologies and biotechnologies. Nanobiotix has developed a new class of therapeutics based on nanoparticles, NanoXray™ therapeutics. They consist of inert nanoparticles designed to enter tumor cells. Upon activation by a standard dose of radiation, they release a tremendous amount of energy that destroys cancer cells, whilst the surrounding healthy tissues are preserved and receive the same dose of radiation as in standard radiotherapy. Founded in 2003, the company is based in Paris.

From
From
From
Cancer Nanomedicine Market & Pipeline Insight 2015 - Product Thumbnail Image

Cancer Nanomedicine Market & Pipeline Insight 2015

  • Drug Pipelines
  • February 2015
  • 220 Pages
From
Nanoparticle Drug Delivery Market & Clinical Pipeline Insight - Product Thumbnail Image

Nanoparticle Drug Delivery Market & Clinical Pipeline Insight

  • Drug Pipelines
  • June 2014
  • 475 Pages
From
Nanotechnology in Medical Applications: The Global Market - Product Thumbnail Image

Nanotechnology in Medical Applications: The Global Market

  • Report
  • September 2017
  • 121 Pages
From
From
Global Cancer Nanomedicine Market Outlook 2022 - Product Thumbnail Image

Global Cancer Nanomedicine Market Outlook 2022

  • Report
  • November 2016
  • 420 Pages
From
From
From
From
Global Nanomedicine Market & Pipeline Insight 2015 - Product Thumbnail Image

Global Nanomedicine Market & Pipeline Insight 2015

  • Drug Pipelines
  • April 2015
  • 330 Pages
From
From
Soft Tissue Sarcoma - Pipeline Insight, 2021 - Product Thumbnail Image

Soft Tissue Sarcoma - Pipeline Insight, 2021

  • Drug Pipelines
  • May 2021
  • 240 pages
From
Loading Indicator
adroll